最新动态 7月15日_老虎社区_美港股上老虎

最新动态 7月15日ProKidney 公司获得 FDA 对 Rilparencel 用于晚期慢性肾病和 2 型糖尿病加速批准路径的支持。

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":456897809605096,"tweetId":"456897809605096","gmtCreate":1752584002743,"gmtModify":1752584800457,"author":{"id":4213768367150342,"idStr":"4213768367150342","authorId":4213768367150342,"authorIdStr":"4213768367150342","name":"克鲁克","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":1,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>最新动态 7月15日ProKidney 公司获得 FDA 对 Rilparencel 用于晚期慢性肾病和 2 型糖尿病加速批准路径的支持。</p></body></html>","htmlText":"<html><head></head><body><p>最新动态 7月15日ProKidney 公司获得 FDA 对 Rilparencel 用于晚期慢性肾病和 2 型糖尿病加速批准路径的支持。</p></body></html>","text":"最新动态 7月15日ProKidney 公司获得 FDA 对 Rilparencel 用于晚期慢性肾病和 2 型糖尿病加速批准路径的支持。","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/456897809605096","repostId":0,"isVote":1,"tweetType":1,"viewCount":461,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":94,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/456897809605096"}